QA: Immunogen Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000855654_2014_Immunogen_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0000855654, Immunogen Inc

  xvar xval
0 AssetsCurrent 200,684,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,783,000
3 remainder_Assets 2,129,000
4 LiabilitiesCurrent 19,173,000
5 LiabilitiesNoncurrent 3,566,000
6 remainder_Liabilities 69,010,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,471,000
9 ResearchAndDevelopmentExpense 87,073,000
10 remainder_Expenses 0
11 remainder_Revenues 35,535,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 198,000
  yvar yval
0 Assets 213,596,000
1 Liabilities 91,749,000
2 Expenses 108,544,000
3 Revenues 35,535,000
4 StockholdersEquity 121,847,000
5 NetIncome -73,009,000
6 ComprehensiveNetIncome -72,910,000
7 BaseVar 224,811,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.26
9 EconomicCapitalRatio 2.50

Edgar->Model Mapping

Feature Distribution

Change over Time